Whalesbook
UltraTech Cement's Expansion Strategy
UltraTech Cement is sticking to its strategy of expanding scale to strengthen its market lead. In FY26, the company added 8 million tonne per annum (MTPA) capacity, reaching 196.8 MTPA, and surpassed 200 MTPA domestic capacity by April 2026. It plans to add another 37 MTPA by FY28, projecting a total capacity above 242.5 MTPA. To support this, UltraTech plans annual capital expenditure of ₹8,000–10,000 crore, investing ₹9,600 crore in FY26. This expansion aims to use cost advantages and broaden its market reach. UltraTech's stock trades around ₹12,000-₹12,041, up 8.6% last month but down 1.9% over the past year. Analysts give it a "Strong Buy" rating, with an average 12-month price target of ₹13,720.54.
Ambuja Cements' Pivot to Profitability
Ambuja Cements is adjusting its growth plan, prioritizing operational improvements and better margins over rapid capacity additions. Committed projects will lift capacity to about 119 MTPA by H1FY27. CEO Vinod Bahety said the focus for FY27 is on making operations more efficient and boosting margins via trade sales and premium products. This is a shift from earlier goals, like a previous target of 140 MTPA by FY28. Ambuja's capital expenditure for FY27 is set between ₹6,000–6,500 crore, down from ₹7,500 crore in FY26. Spending will be flexible based on market conditions. Ambuja has also completed the integration of Sanghi and Penna Cement. Ambuja's stock trades around ₹433-₹447, down 20% over the past year but up 0.7% last month. Analysts rate it a "Moderate Buy," with an average 12-month price target of ₹586.67, suggesting over 25% potential upside.
Valuation Differences and Sector Outlook
These different strategies are reflected in their market valuations. UltraTech Cement, with a market capitalization nearing ₹3.53 lakh crore, trades at a P/E ratio of approximately 43. Ambuja Cements, valued around ₹1.11 lakh crore, has a P/E closer to 29.5. Competitors like Shree Cement trade at a P/E of 50-72, while Dalmia Bharat's P/E often exceeds 260, showing varied investor perceptions. The Indian cement industry is projected to grow 7-8% in FY27, fueled by housing and infrastructure demand. The Union Budget 2026-27's increased public capital expenditure of ₹12.2 lakh crore supports this. However, early FY27 profitability may face pressure from rising input costs like fuel and freight, potentially impacting margins by 6-11%.
Potential Risks for Both Companies
UltraTech's aggressive expansion strategy requires significant capital and sustained demand to justify its high annual capex of ₹8,000-₹10,000 crore, despite aiming for long-term cost efficiencies. A construction slowdown could strain its balance sheet. However, its 'BBB-' rating from Fitch with a stable outlook suggests strong financial management, projecting EBITDA net leverage to remain around 1.5x. For Ambuja, shifting to optimization risks losing market share to rivals focused on expansion if demand growth accelerates faster than expected. While focusing on margins is financially sound, it could limit its long-term competitive advantage against larger players like UltraTech. Ambuja's debt-free status offers a strong financial cushion. However, outperforming industry growth depends on strategic acquisitions or renewed expansion efforts.
Future Outlook
Despite potential margin pressures from input costs, analysts remain largely positive on both companies. UltraTech Cement is widely rated a "Strong Buy," with price targets indicating further upside. Ambuja Cements, rated a "Moderate Buy," also offers a good balance of risk and reward, with price targets suggesting considerable growth potential. The cement sector's growth, supported by government policy and domestic demand, provides a supportive environment for these different strategies.